Differences in Choroidal Vascularity Index Between Migraine Patients in the Attack-free Period and Normal Individuals

Basit Öğe Kaydı
dc.authorscopusid57114878000en_US
dc.authorscopusid58146014400en_US
dc.authorscopusid58525080300en_US
dc.contributor.authorSezer, T.
dc.contributor.authorAyaslı, A.A.H.
dc.contributor.authorMeydan, B.
dc.date.accessioned2024-08-23T16:07:24Z
dc.date.available2024-08-23T16:07:24Z
dc.date.issued2023en_US
dc.departmentDüzce Üniversitesien_US
dc.description.abstractPurpose: Migraine is a neurovascular disorder characterized by recurrent headaches. The relationship between migraine disease and the choroid, has been examined in an attempt to elucidate the underlying pathophysiological mechanisms. This study evaluated CT (choroidal thickness) and choroidal vascularity index (CVI) in chronic migraine patients. Materials and Methods: In this prospective study, we compared CT and CVI values of 36 chronic migraine patients (30 women and 6 men) during an attack-free period with those of 36 healthy individuals (30 women and 6 men) with no systemic or ocular disease, including headache. All patients underwent a detailed eye examination. Migraine patients were grouped as those with and without aura and were asked to rate their headache severity on visual analog scale (VAS; range 1-10) and estimate their monthly migraine frequency. Results: The mean subfoveal CT (SFCT) was 300.52 ± 88.30 µm in the migraine group and 262.85 ± 70.68 µm in the control group. The mean CVI was 71.8% ± 6.2% in the migraine group and 70.7% ± 5.3% in the control group. SFCT and CVI did not differ significantly between the migraine and control groups (p>0.05). VAS pain score was 8.17 ± 0.33 in the migraine group and was not correlated with SFCT (r=0, p=0.998) or CVI (r=-0.06, p=0.731). The monthly migraine frequency was 5.60 ± 3.60 and was not correlated with SFCT (r=-0.17, p=0.328) or CVI (r=-0.06, p=0.731). Conclusion: CT and CVI showed no significant differences from controls in chronic migraine patients during an attack-free period. © 2023 Gazi Eye Foundation. All rights reserved.en_US
dc.identifier.doi10.37845/ret.vit.2023.32.19
dc.identifier.endpage116en_US
dc.identifier.issn1300-1256
dc.identifier.issue2en_US
dc.identifier.scopus2-s2.0-85166953310en_US
dc.identifier.scopusqualityQ4en_US
dc.identifier.startpage110en_US
dc.identifier.trdizinid1185298en_US
dc.identifier.urihttps://doi.org/10.37845/ret.vit.2023.32.19
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/1185298
dc.identifier.urihttps://hdl.handle.net/20.500.12684/14640
dc.identifier.volume32en_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakTR-Dizinen_US
dc.language.isoenen_US
dc.publisherGazi Eye Foundationen_US
dc.relation.ispartofRetina-Vitreusen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectChoroidal thicknessen_US
dc.subjectChoroidal vascularity indexen_US
dc.subjectMigraineen_US
dc.subjectOptical coherence tomographyen_US
dc.subjectnonsteroid antiinflammatory agenten_US
dc.subjectadulten_US
dc.subjectArticleen_US
dc.subjectB scanen_US
dc.subjectbest corrected visual acuityen_US
dc.subjectcase control studyen_US
dc.subjectchoroidal thicknessen_US
dc.subjectchoroidal vascularity indexen_US
dc.subjectclinical articleen_US
dc.subjectcontrolled studyen_US
dc.subjectdisease courseen_US
dc.subjecteye diseaseen_US
dc.subjecteye examinationen_US
dc.subjectfemaleen_US
dc.subjectheadacheen_US
dc.subjecthumanen_US
dc.subjectmaleen_US
dc.subjectmigraine with auraen_US
dc.subjectmigraine without auraen_US
dc.subjectophthalmoscopyen_US
dc.subjectpain severityen_US
dc.subjectpredictive valueen_US
dc.subjectprospective studyen_US
dc.subjectrefraction erroren_US
dc.subjectrisk factoren_US
dc.subjectslit lamp microscopyen_US
dc.subjectspectral domain optical coherence tomographyen_US
dc.subjectsystemic diseaseen_US
dc.subjecttransformed migraineen_US
dc.subjectvisual analog scaleen_US
dc.titleDifferences in Choroidal Vascularity Index Between Migraine Patients in the Attack-free Period and Normal Individualsen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
14640.pdf
Boyut:
695.67 KB
Biçim:
Adobe Portable Document Format
İndir

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
TR-Dizin İndeksli Yayınlar Koleksiyonu